Aurora Cannabis Enterprises Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Aurora Cannabis Enterprises Inc. - overview

Established

2013

Location

Edmonton, AB, Canada

Primary Industry

Healthcare

About

Aurora Cannabis Enterprises Inc. is a Canadian company focused on the production and distribution of cannabis products, catering to both medical and recreational markets. Founded in 2013 in Edmonton, Canada, Aurora Cannabis Enterprises Inc. specializes in the cultivation, production, and distribution of cannabis.


The company has undergone strategic shifts but has remained committed to expanding its footprint in the cannabis sector. It has been involved in three deals as of November 2020, raising a total of USD 172. 5 mn through the latest funding round, a Private Placement/Follow on. The CEO is Miguel Martin.


Aurora Cannabis Enterprises Inc. provides a range of cannabis products including dried flower, oils, and capsules. Its offerings cater to both medical and recreational users, meeting diverse consumer needs while ensuring compliance with regulations in various markets. The company's products are marketed across North America, Europe, and selected Asian markets, with a strong emphasis on quality and innovation.


The company generates revenue primarily through direct sales of its cannabis products. Contracts with both medical and retail sectors ensure a consistent revenue stream. Clients typically engage with Aurora for varying amounts of product, aligning with their specific consumption or therapeutic needs. The company also benefits from partnerships that enhance its distribution capabilities.


Looking forward, Aurora Cannabis Enterprises Inc. plans to launch new product lines targeted for release in 2021, expanding its offerings to include innovative cannabis-infused products. The company aims to penetrate additional markets in Europe and Asia by the end of 2021, leveraging the financial flexibility gained from the USD 172. 5 mn raised in November 2020.


This funding is intended to support product development and market entry strategies, following the recent sale of their remaining stake in Cann Group Limited for AUD 13. 40 mn.


Current Investors

Alumina Partners

Primary Industry

Healthcare

Sub Industries

Alternative Medicine, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals

Website

www.auroramj.com

Verticals

HealthTech

Company Stage

Mature

Total Amount Raised

Subscriber access only

Aurora Cannabis Enterprises Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedSafari Flower Co.-
Add-on, Trade SaleAnnouncedBevo Agro Inc.-
Add-onCompletedTerraFarma Inc.-
Private Placement/Follow onCompletedAurora Cannabis Enterprises Inc.-
Unspecified ExitCompletedAurora Cannabis Enterprises Inc.-

Displaying 1 - 5 of 12

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.